Results 151 to 160 of about 85,022 (329)

Posttransplant T lymphoblastic lymphoma mimicking Burkitt lymphoma [PDF]

Blood, 2021
Jirong Mass, David C. Park
openaire   +3 more sources

Multimodal Image Analysis of Chronic Leukemic Lymphoproliferative Disorders and the Hypothesis of »Single« and »Multiple« Programmed Stops in the Development of Typical and Atypical Forms of Leukemias and Lymphomas [PDF]

, 2010
The study consisted of morphometric analysis, assessment of the argyrophilic nucleolar organization region (AgNOR) characteristics, and image cytometry (ICM) in different tumor mass compartments: bone marrow (BM), peripheral blood (PB) and lymph nodes ...
Biljana Jelić Puškarić, Branimr Jakšić, Delfa Radić-Krišto, Ika Kardum-Skelin, Matko Kardum, Ozren Jakšić   +5 more
core   +2 more sources

CLOX and neurotox: Utility of the clock drawing task in monitoring for immune effector cell‐associated neurotoxicity syndrome following chimeric antigen receptor T‐cell therapy

British Journal of Haematology, EarlyView.
Summary Immune effector cell‐associated neurotoxicity syndrome (ICANS)‐associated cognitive impairment is common in patients who receive chimeric antigen receptor T‐cell (CAR‐T) therapy. This study evaluated the utility of the clock drawing task (CDT) in detecting ICANS in patients with haematological cancers following CAR‐T therapy.
Christina Kazzi, Ty Simpson, Miriam Wronski, Nabil Seery, Robb Wesselingh, Tracie H. Tan, Katherine Y. Ko, Daniel J. Pearce, Cassandra Abbott, Jian Li, Sarah P. Griffith, Shu Min Wong, Michael Westworth, Shafqat Inam, Constantine S. Tam, Shaun Fleming, Anneke Van Der Walt, Terence J. O'Brien, Rubina Alpitsis, Andrew Spencer, Charles B. Malpas, Paul Sanfilippo, Mastura Monif   +22 more
wiley   +1 more source

Expression of A-myb, but not c-myb and B-myb, is restricted to Burkitt's lymphoma, sIg+ B-acute lymphoblastic leukemia, and a subset of chronic lymphocytic leukemias [PDF]

, 1996
Josée Golay, Mario Luppi, Simona Songia, C Palvarini, L. Tallone Lombardi, Antonella Aiello, D Delia, King H. Lam, DH Crawford, Andrea Biondi, Tiziano Barbui, Alessandro Rambaldi, Martino Introna   +12 more
openalex   +1 more source

RBM39 Promotes Base Excision Repair to Facilitate the Progression of HCC by Stabilising OGG1 mRNA

Cell Proliferation, EarlyView.
Targeting RBM39 attenuates BER via destabilising OGG1 mRNA and potentiates KBrO3‐induced oxidative stress in HCC. Our study represents a valuable treatment strategy combining indisulam and an oxidative stress inducer in HCC. ABSTRACT Targeting base excision repair (BER) has been an attractive strategy in cancer therapeutics.
Hongda An, Anliang Xia, Siyuan Liu, Dongjun Luo, Longpo Geng, Binghua Li, Beicheng Sun, Zhu Xu   +7 more
wiley   +1 more source

Hepatic Dysfunction during Induction Chemotherapy in Children with Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma and Its Effects on Subsequent Therapy and Outcome

Indian Journal of Medical and Paediatric Oncology
Introduction The overall survival rate for childhood acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LBL) has shown tremendous growth in the recent years.
Nalla Anuraag Reddy, Keerthi Raj, Harsha Prasada Lashkari   +2 more
doaj   +1 more source

PI5P4K inhibitors: promising opportunities and challenges

The FEBS Journal, EarlyView.
Developing inhibitors is like climbing a steep, challenging mountain. PI5P4K inhibitors hold significant promise for the treatment of cancer, immune disorders, and neurological diseases. However, the path to success is fraught with hurdles, and researchers are therefore required to apply their expertise to overcome critical “checkpoints.” While some ...
Koh Takeuchi, Lisa Nagase, Shun Kageyama, Hirotaka Kanoh, Masashi Oshima, Aki Ogawa‐Iio, Yoshiki Ikeda, Yuki Fujii, Sei Kondo, Natsuki Osaka, Takeshi Masuda, Tsukasa Ishihara, Yoshikazu Nakamura, Yoshihisa Hirota, Takehiko Sasaki, Toshiya Senda, Atsuo T. Sasaki   +16 more
wiley   +1 more source

Development and Validation of a Quantitative Polymerase Chain Reaction Assay to Evaluate Minimal Residual Disease for T-Cell Acute Lymphoblastic Leukemia and Follicular Lymphoma [PDF]

, 1999
Gregory A. Hosler, Robert O. Bash, Xin Bai, Vinay Jain, Richard H. Scheuermann   +4 more
openalex   +1 more source

CRISPR‐Cas9 screen reveals that inhibition of enhancer of zeste homolog 2 sensitizes malignant T cells to dimethyl‐fumarate‐induced cell death

The FEBS Journal, EarlyView.
A genome‐wide CRISPR‐Cas9 screen identified H3K27 methylation as a key regulator of T‐cell lymphoma sensitivity to dimethyl fumarate (DMF). Specifically, inhibition of enhancer of zeste homolog 2 (EZH2) enhanced DMF‐induced cell death in malignant T cells. These results provide functional evidence for the role of EZH2 in modulating drug sensitivity and
Jan P. Teubner, Deniz Tümen, Arne Kandulski, Philipp Heumann, Patricia Mester, Elisabeth Aschenbrenner, Kirstin Pollinger, Manuela Gunckel, Barbara Volz, Tobias Hein, Paul L. Beltzig, Luisa Tengler, Florian Voll, Marina Kreutz, Claudia Kunst, Jan P. Nicolay, Martina Müller, Karsten Gülow   +17 more
wiley   +1 more source

Long-term Follow-up Results of Adult Patients with Acute Lymphocytic Leukemia or Lymphoblastic Lymphoma Treated with Short-term, Alternating Non-cross-resistant Chemotherapy: Japan Clinical Oncology Group Study 8702 [PDF]

, 1999
Yukio Kobayashi, Kensei Tobinai, M Shimoyama, C Mikuni, S Konda, Mitsuo Kozuru, Koichi Araki, T. Sai, Shunichi Fukuhara, M Matsumoto, I Aoki, Kijo Deura, Atsushi Oyama, T Hotta, Tetsuya Abe, H Toki, María Aparecida Nagai, Haruhiko Fukuda, Miyuki Niimi, Nobuyasu Yamaguchi, Kinuko Tajima, S. Shirakawa   +21 more
openalex   +1 more source